In older adults, an Ad26.RSV.preF-RSV preF protein vaccine reduced RSV-related lower respiratory tract disease

被引：2
|
作者：
Awar, Melina [1 ]
Mylonakis, Eleftherios [1 ]
机构：
[1] Houston Methodist Hosp, Houston, TX 77030 USA
来源：
ANNALS OF INTERNAL MEDICINE | 2023年 / 176卷 / 06期
关键词：
D O I：
10.7326/J23-0039
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Source Citation Falsey AR, Williams K, Gymnopoulou E, et al; CYPRESS Investigators. Efficacy and safety of an Ad26.RSV.preF-RSV preF protein vaccine in older adults. N Engl J Med. 2023;388:609-620. 36791161 Clinical Impact Ratings GIM/FP/GP: GIM/FP/GP: Geriatrics: Infectious Disease: Pulmonology: Public Health:
引用
收藏
页码：JC63 / JC63
页数：1
相关论文
共 50 条
  • [21] Prevention of Respiratory Syncytial Virus Infection in Healthy Adults by a Single Immunization of Ad26.RSV.preF in a Human Challenge Study
    Sadoff, Jerald
    De Paepe, Els
    DeVincenzo, John
    Gymnopoulou, Efi
    Menten, Joris
    Murray, Bryan
    Rosemary Bastian, Arangassery
    Vandebosch, An
    Haazen, Wouter
    Noulin, Nicolas
    Comeaux, Christy
    Heijnen, Esther
    Eze, Kingsley
    Gilbert, Anthony
    Lambkin-Williams, Rob
    Schuitemaker, Hanneke
    Callendret, Benoit
    JOURNAL OF INFECTIOUS DISEASES, 2022, 226 (03): : 396 - 406
  • [22] Efficacy and Immunogenicity of an Ad26.RSV.preF-based Vaccine in the Prevention of RT-PCR-confirmed RSV-mediated Lower Respiratory Tract Disease in Adults Aged ≥65 Years: A Randomized, Placebo-controlled, Phase 2b Study
    Falsey, Ann
    Williams, Kristi
    Gymnopoulou, Efi
    Bart, Stephan
    Ervin, John
    Bastian, Arangassery Rosemary
    Menten, Joris
    De Paepe, Els
    de Boer, Hilde
    Vandenberghe, Sjoukje
    Chan, Eric
    Sadoff, Jerald
    Douoguih, Macaya
    Callendret, Benoit
    Comeaux, Christy
    Heijnen, Esther
    INTERNIST, 2022, 63 (SUPPL 3): : 344 - 344
  • [23] In older adults, an AS01E-adjuvanted RSVPreF3 OA vaccine reduced RSV-related lower respiratory tract disease (vol 176, pg JC62, 2023)
    Awar, M.
    ANNALS OF INTERNAL MEDICINE, 2023, 176 (12) : JC144 - JC144
  • [24] PRIMARY CARE PHYSICIANS' PERSPECTIVES ON RESPIRATORY SYNCYTIALVIRUS (RSV) DISEASE IN ADULTS AND A POTENTIAL RSV VACCINE FOR ADULTS
    Hurley, Laura P.
    Allison, Mandy
    Kim, Lindsay
    O'Leary, Sean T.
    Crane, Lori A.
    Brtnikova, Michaela
    Beaty, Brenda
    Allen, Kristen
    Poser, Sarah
    Lindley, Megan C.
    Kempe, Allison
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2018, 33 : S305 - S306
  • [25] PREVALENCE OF RSV AMONG ACUTE LOWER RESPIRATORY TRACT DISEASE (ALRTD) HOSPITALIZATIONS AND PROJECTED SEASONAL RSV-RELATED ALRTD HOSPITALIZATION INCIDENCE AMONG ADULTS IN BRISTOL UK-2022-2023
    Adegbite, D.
    Begier, E.
    King, J.
    Southern, J.
    McGuinness, S.
    Hubler, R.
    Oliver, J.
    Vyse, A.
    Aliabadi, N.
    Gessner, B.
    Finn, A.
    Hyams, C.
    THORAX, 2023, 78 (SUPPL_4) : A93 - A94
  • [26] Phase 1 Safety and Immunogenicity Study of a Respiratory Syncytial Virus Vaccine With an Adenovirus 26 Vector Encoding Prefusion F (Ad26.RSV.preF) in Adults Aged ≥60 Years
    Williams, Kristi
    Bastian, Arangassery Rosemary
    Feldman, Robert Allen
    Omoruyi, Edmund
    de Paepe, Els
    Hendriks, Jenny
    van Zeeburg, Hester
    Godeaux, Olivier
    Langedijk, Johannes P. M.
    Schuitemaker, Hanneke
    Sadoff, Jerry
    Callendret, Benoit
    JOURNAL OF INFECTIOUS DISEASES, 2020, 222 (06): : 979 - 988
  • [27] Improved RSV preF protein vaccine quality and stability by elucidation of supercooling-induced aggregation phenomena
    Cui, Tao Ju
    Beugeling, Max
    Kaserer, Wallace
    Heugten, Anton J. P. van
    Capelle, Martinus A. H.
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2024, 203
  • [28] Pathogenesis of RSV lower respiratory tract infection: implications for vaccine development
    Brandenburg, AH
    Neijens, HJ
    Osterhaus, ADME
    VACCINE, 2001, 19 (20-22) : 2769 - 2782
  • [29] A Phase 1/2a Study Evaluating Safety and Immunogenicity of Ad26.RSV.preF in RSV-seronegative Toddlers Aged 12-24 Months
    Langley, Joanne M.
    Nolan, Terry M.
    Ramet, Mika
    Richmond, Peter C.
    Rosario Filho, Nelson
    Haazen, Wouter
    van den Berg, Sara P. H.
    Williams, Kristi
    Bastian, Arangassery Rosemary
    Omoruyi, Edmund
    Durkin, Joanna Williams
    Salisch, Nadine
    Van Geet, Gunter
    van Duijnhoven, Wilbert
    Heijnen, Esther
    Callendret, Benoit
    OPEN FORUM INFECTIOUS DISEASES, 2024, 11 (09):
  • [30] Primary care physician's perspectives on respiratory syncytial virus (RSV) disease in adults and a potential RSV vaccine for adults
    Hurley, Laura P.
    Allison, Mandy A.
    Kim, Lindsay
    O'Leary, Sean T.
    Crane, Lori A.
    Brtnikova, Michaela
    Beaty, Brenda L.
    Allen, Kristen E.
    Poser, Sarah
    Lindley, Megan C.
    Kempe, Allison
    VACCINE, 2019, 37 (04) : 565 - 570
12345